Symrise has launched an in depth investigation into its deodorant active SymDeo B125. Long term efficacy of the active has been known for many years, however Research & Development has discovered additional key advantages: In contrast to the conventional antimicrobial triclosan, SymDeo B125 has no negative impact on the axillary microbiome.
10 years ago, Symrise introduced SymDeo B125, an effective and readily biodegradable deodorant active. It is used in typical underarm cosmetic products, and has also proven effective in foot care and many other cosmetic formulations. Symrise researchers have now been able to show that this deodorant active is microbiome friendly and does not disrupt the sensitive underarm biota notably. Symrise ́s findings regarding the influence of deo actives on the human axillary microbiome are the first in the industry. This underlines Symrise ́s pioneer position in the field of modern Micro Protection.
‘Globally, we are observing a growing interest in exploring the impact of personal care products on healthy skin,’ says Dr Florian Genrich, senior global product manager Micro Protection in the Cosmetic Ingredients Division at Symrise. ‘Consequently, cosmetic manufacturers are facing continuously increasing expectations from the consumer side, which requires the industry to keep up with state of the art technologies. As a manufacturer of cosmetic ingredients, we continuously conduct intensive research on our ingredients and explore new methods, such as in the field of skin microbiome analysis. We are proud to deliver our customers additional benefits also within our existing and versatile product portfolio.’